









市场行情
/
股票
/
nasdaq-mmsi
/

Merit Medical Systems Inc

MMSI

84.540USD

+0.590+0.70%

收盘 07/17, 16:00（美东）报价延迟15分钟

4.99B总市值

40.85市盈率 TTM



Merit Medical Systems Inc

84.540

+0.590+0.70%

概览公司财务

Merit Medical Systems, Inc. 从事专有医疗设备的开发、制造和分销，这些设备用于介入、诊断和治疗程序，特别是心脏病学、放射学、肿瘤学、重症监护和内窥镜检查。其部门包括心血管和内窥镜检查。其心血管部门包括四个产品类别：外周介入、心脏介入、定制程序解决方案和原始设备制造商 (OEM)。其内窥镜部门包括胃肠病学和肺病学设备，这些设备可帮助姑息治疗扩张的食管、气管支气管和胆道狭窄。其医疗设备和配件产品组合用于导线管理程序，适用于需要移除或更换起搏器或植入式心律转复除颤器导线的患者。其电生理学和心律管理产品组合包括可操纵技术和其他专业技术。

公司简介

公司代码MMSI

公司名称Merit Medical Systems Inc

上市日期Sep 16, 1954

成立日期1987

CEO- -

员工数量7400

证券类型Ordinary Share

年结日Sep 16

公司地址1600 West Merit Park Way

城市SOUTH JORDAN

上市交易所NASDAQ Global Select Consolidated

国家United States of America

邮编84095

电话18012531600

网址https://www.merit.com/

公司代码MMSI

上市日期Sep 16, 1954

成立日期1987

公司高管

名称

名称/职务

职务

持股

持股变动

Mr. Fred P. Lampropoulos

Chairman of the Board

1.11M

-0.93%

Mr. Thomas James Gunderson

Independent Director

36.03K

+6.35%

Mr. Brian G. Lloyd

Chief Legal Officer, Corporate Secretary

21.70K

-44.35%

Mr. David K. Floyd

Independent Director

18.58K

+13.10%

Mr. Lonny J. Carpenter

Independent Director

17.37K

+14.14%

Mr. Neil W. Peterson

Chief Operating Officer

16.61K

Rear Adm. (Retd.) Stephen C. Evans

Independent Director

6.81K

+46.21%

Mr. Michael R. (Mike) McDonnell, CPA

Independent Director

3.96K

-30.63%

Dr. F. Ann Millner, Ed.D.

Lead Independent Director

Mr. Michel J. Voigt

Chief Human Resources Officer

名称

名称/职务

职务

持股

持股变动

Mr. Fred P. Lampropoulos

Chairman of the Board

1.11M

-0.93%

Mr. Thomas James Gunderson

Independent Director

36.03K

+6.35%

Mr. Brian G. Lloyd

Chief Legal Officer, Corporate Secretary

21.70K

-44.35%

Mr. David K. Floyd

Independent Director

18.58K

+13.10%

Mr. Lonny J. Carpenter

Independent Director

17.37K

+14.14%

Mr. Neil W. Peterson

Chief Operating Officer

16.61K

收入明细

单位: USD更新时间: 7月6日周日

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

业务USD

名称

营收

占比

Peripheral Intervention

137.28M

38.63%

Cardiac Intervention

99.74M

28.07%

OEM

53.75M

15.13%

Custom Procedural Solutions

47.94M

13.49%

Endoscopy devices

16.64M

4.68%

地区USD

名称

营收

占比

United States

213.56M

60.10%

International

141.79M

39.90%

业务

地区

业务USD

名称

营收

占比

Peripheral Intervention

137.28M

38.63%

Cardiac Intervention

99.74M

28.07%

OEM

53.75M

15.13%

Custom Procedural Solutions

47.94M

13.49%

Endoscopy devices

16.64M

4.68%

股东统计

更新时间: 5月17日周六

持股股东

股东类型

持股股东

占比

BlackRock Institutional Trust Company, N.A.

13.84%

The Vanguard Group, Inc.

11.10%

Conestoga Capital Advisors, LLC

3.83%

State Street Global Advisors (US)

3.71%

Fuller & Thaler Asset Management Inc.

2.99%

Other

64.53%

持股股东

占比

BlackRock Institutional Trust Company, N.A.

13.84%

The Vanguard Group, Inc.

11.10%

Conestoga Capital Advisors, LLC

3.83%

State Street Global Advisors (US)

3.71%

Fuller & Thaler Asset Management Inc.

2.99%

Other

64.53%

股东类型

持股股东

占比

Investment Advisor/Hedge Fund

47.16%

Investment Advisor

45.45%

Hedge Fund

8.30%

Research Firm

3.48%

Individual Investor

2.28%

Bank and Trust

1.98%

Pension Fund

1.65%

Sovereign Wealth Fund

1.23%

Insurance Company

0.08%

机构持股

更新时间: 7月1日周二

报告期

机构数

持股数

持股占比

持股变动

2025Q2

747

65.96M

111.61%

-316.93K

2025Q1

779

66.66M

112.79%

+221.37K

2024Q4

755

63.98M

108.78%

+576.77K

2024Q3

725

62.16M

106.75%

-1.49M

2024Q2

695

63.02M

108.42%

-345.52K

2024Q1

677

61.08M

105.16%

-692.46K

2023Q4

651

59.77M

103.51%

-88.47K

2023Q3

637

57.87M

100.40%

-723.38K

2023Q2

625

56.54M

98.35%

-2.22M

2023Q1

600

56.86M

99.01%

-1.64M

股东持股明细

名称

持股数

占比

持股变动

变动比例

公告日期

BlackRock Institutional Trust Company, N.A.

8.18M

13.84%

-174.56K

-2.09%

Mar 31, 2025

The Vanguard Group, Inc.

6.56M

11.1%

-77.00K

-1.16%

Mar 31, 2025

Conestoga Capital Advisors, LLC

2.27M

3.83%

-24.73K

-1.08%

Mar 31, 2025

State Street Global Advisors (US)

2.19M

3.71%

-99.26K

-4.33%

Mar 31, 2025

Fuller & Thaler Asset Management Inc.

1.77M

2.99%

+133.47K

+8.17%

Mar 31, 2025

Fidelity Management & Research Company LLC

1.47M

2.49%

+206.25K

+16.29%

Mar 31, 2025

Macquarie Investment Management

1.45M

2.46%

+2.73K

+0.19%

Mar 31, 2025

Geode Capital Management, L.L.C.

1.40M

2.37%

+40.56K

+2.99%

Mar 31, 2025

Invesco Advisers, Inc.

1.35M

2.28%

+47.94K

+3.69%

Mar 31, 2025

Maverick Capital, Ltd.

1.27M

2.15%

+1.27M

Mar 31, 2025

持股ETF

更新时间: 7月6日周日

机构名称

占比

Invesco S&P SmallCap Health Care ETF

3.96%

Invesco Dorsey Wright Healthcare Momentum ETF

3.18%

AAM Sawgrass US Small Cap Quality Growth ETF

2.1%

First Trust Indxx Medical Devices ETF

1.92%

SPDR S&P Health Care Equipment ETF

1.79%

Invesco S&P SmallCap Momentum ETF

1.37%

Pacer US Small Cap Cash Cows Growth Leaders ETF

1.11%

iShares MSCI USA Small-Cap Min Vol Factor ETF

1.06%

ETC 6 Meridian Small Cap Equity ETF

1.05%

Thrivent Small-Mid Cap ESG ETF

1.05%

Invesco S&P SmallCap Health Care ETF

占比3.96%

Invesco Dorsey Wright Healthcare Momentum ETF

占比3.18%

AAM Sawgrass US Small Cap Quality Growth ETF

占比2.1%

First Trust Indxx Medical Devices ETF

占比1.92%

SPDR S&P Health Care Equipment ETF

占比1.79%

Invesco S&P SmallCap Momentum ETF

占比1.37%

Pacer US Small Cap Cash Cows Growth Leaders ETF

占比1.11%

iShares MSCI USA Small-Cap Min Vol Factor ETF

占比1.06%

ETC 6 Meridian Small Cap Equity ETF

占比1.05%

Thrivent Small-Mid Cap ESG ETF

占比1.05%

分红派息

近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股

公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

KeyAI

